# MIRACLE-T2D Montelukast Intervention for Renal, Cardiovascular and Eye Health in Type 2 Diabetes

> **NCT07685886** · PHASE4 · NOT_YET_RECRUITING · sponsor: **University of Colorado, Denver** · enrollment: 110 (estimated)

## Conditions studied

- Diabetes
- Kidney Disease
- Vascular Disease
- Retinopathy

## Interventions

- **DRUG:** Montelukast
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07685886
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2031-06-30
- **Final completion:** 2031-08-31
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2026-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07685886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07685886, "MIRACLE-T2D Montelukast Intervention for Renal, Cardiovascular and Eye Health in Type 2 Diabetes". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07685886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*